tiprankstipranks
Trending News
More News >
JBT Marel (JBTM)
NYSE:JBTM
Advertisement

JBT Marel (JBTM) AI Stock Analysis

Compare
249 Followers

Top Page

JBTM

JBT Marel

(NYSE:JBTM)

Rating:72Outperform
Price Target:
$155.00
▲(8.17% Upside)
JBT Marel's overall score is driven by strong financial performance in revenue growth and cash flow, positive technical indicators, and favorable earnings call sentiment. However, profitability challenges and a negative P/E ratio weigh on the valuation score.
Positive Factors
Demand and Orders
Orders were driven by broad-based strength in poultry, meat, fruit and vegetables, and ready meals.
Earnings
Upgrading JBT Marel to Outperform, from Market Perform, following the company’s strong second-quarter results.
Financial Performance
The company reported a record quarter of aftermarket parts, which drove a favorable mix, resulting in adjusted EBITDA margins exceeding expectations.
Negative Factors
Guidance Uncertainty
The decision to suspend full year 2025 guidance appears to stem from an abundance of caution, with JBT Marel calling out prolonged periods of macro uncertainty as historically poor for the more cyclical equipment piece of the business.
Managerial Challenges
The largest issue is managerial bandwidth against a backdrop of decision paralysis due to ongoing tariff uncertainty.
Tariff Concerns
The looming potential of 50% EU tariffs adds another layer of complexity during an already complex integration process.

JBT Marel (JBTM) vs. SPDR S&P 500 ETF (SPY)

JBT Marel Business Overview & Revenue Model

Company DescriptionJBT Marel Corporation provides technology solutions to food and beverage industry in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers value-added processing that includes chilling, mixing/grinding, injecting, blending, marinating, tumbling, flattening, forming, portioning, coating, cooking, frying, freezing, extracting, pasteurizing, sterilizing, concentrating, high pressure processing, weighing, inspecting, filling, closing, sealing, end of line material handling, and packaging solutions to the food, beverage, and health market. In addition, it offers automated guided vehicle systems for material movement in the manufacturing, warehouse, and medical facilities. It serves baby food, bakery and confectionery, citrus processing, fruits and nuts, juices, non-food, pet food, pharmaceutical, plant- based beverages and protein, poultry, meat, and seafood, ready meals, oils, soups, sauces, seasoning and dressings, automotive, building material, tissue, paper, and packaging, hospitals, pharma and life sciences, fast moving consumer goods, manufacturing, warehousing, and other industries. The company markets and sells its products and solutions through direct sales force, independent distributors, sales representatives, and technical service teams. The company was formerly known as John Bean Technologies Corporation and changed its name to JBT Marel Corporation in January 2025. JBT Marel Corporation was incorporated in 1994 and is headquartered in Chicago, Illinois.
How the Company Makes MoneyJBT Marel generates revenue through multiple streams, including the sale of processing equipment, systems, and automation solutions to food manufacturers. The company also earns income from service contracts, maintenance, and spare parts, which provide ongoing support to its clients after the initial equipment purchase. Additionally, JBTM forms strategic partnerships with industry leaders and leverages its technological expertise to develop tailored solutions, thereby enhancing its market presence and driving sales. The recurring nature of its service agreements contributes to a stable revenue base, while new product innovations and expansions into emerging markets further bolster its earnings potential.

JBT Marel Earnings Call Summary

Earnings Call Date:Aug 04, 2025
(Q2-2025)
|
% Change Since: |
Next Earnings Date:Nov 06, 2025
Earnings Call Sentiment Positive
The earnings call reflects a generally positive sentiment with strong revenue performance, improved EBITDA margins, progress in deleveraging, and successful integration synergies. However, challenges remain with tariff costs impacting margins and softness in certain market segments.
Q2-2025 Updates
Positive Updates
Strong Revenue and Order Performance
Total revenue for Q2 2025 was $935 million, exceeding the midpoint of guidance by $35 million. Orders totaled $938 million, with $22 million from favorable FX translation.
Improved EBITDA Margins
Adjusted EBITDA margin was 16.7%, outperforming guidance by 180 basis points, due to favorable revenue mix, productivity improvements, and cost controls.
Progress in Deleveraging
Leverage decreased to below 3.4x from 3.8x in Q1. Bank leverage ratio was 2.8x as of June 30, providing significant liquidity of approximately $1.3 billion.
Integration Synergies Achieved
Year-over-year synergy savings of $5 million in operating expense and $3 million in supply chain, on track for $35-40 million in-year savings, with annualized run rate savings of $80-90 million.
Expanded Portfolio and Cross-Selling Opportunities
Cross-selling and integration of JBT and Marel solutions led to a 15% increase in the pipeline of opportunities in North America. Integrated lines and software provide value to customers.
Negative Updates
Tariff Costs Impacting Margins
Incurred $9 million in gross tariff costs in Q2 2025, with net impact offset by inventory benefits and mitigating actions. Continued tariff challenges expected in the back half of the year.
Soft Performance in Certain Segments
Pharma and pet food demand was softer, while seafood and material handling were neutral. North America was relatively soft, and Asia Pacific remains choppy.
Impairment Charge
An $11 million impairment charge was incurred on a joint venture investment, which was exited as a result of the JBT combination with Marel.
Company Guidance
In the earnings conference call for the second quarter of 2025, JBT Marel provided a comprehensive update on their financial performance and future guidance. The company reported total revenue of $935 million, exceeding expectations by $35 million, with $21 million attributed to favorable foreign exchange impacts. Adjusted EBITDA margins were at 16.7%, outperforming guidance by 180 basis points, driven by a favorable mix of recurring revenue and higher-margin equipment. The company generated strong free cash flow of $88 million in the quarter, contributing to a reduction in leverage to below 3.4x. JBT Marel reestablished full-year guidance, expecting total revenue of $3.7 billion, adjusted EBITDA margins between 15.25% to 16%, and adjusted EPS of $5.45 to $6.15. The integration of JBT and Marel is on track, with synergy savings expected to reach $35 million to $40 million in 2025, with an annualized run rate of $80 million to $90 million by year-end. The backlog stood at $1.4 billion, providing strong support for revenue conversion in the remainder of the year. Despite challenges, such as a $9 million gross tariff cost in Q2, the company is optimistic about continued growth in key markets, notably poultry, and the benefits from its integrated solutions and expanded service network.

JBT Marel Financial Statement Overview

Summary
JBT Marel exhibits a stable financial foundation with strong cash generation capabilities and improved balance sheet strength. However, the recent net loss and declining profit margins highlight the need for operational efficiencies and cost control.
Income Statement
65
Positive
The income statement shows a mixed performance. The revenue growth rate for TTM is strong compared to the previous annual period, but the company posted a negative net income. Gross profit margin remains healthy, yet the net profit margin is concerning due to the significant net loss in the TTM. EBIT and EBITDA margins have decreased, reflecting challenges in maintaining operational efficiency.
Balance Sheet
72
Positive
The balance sheet is relatively robust with a high equity ratio, indicating strong capitalization. Debt levels have been reduced significantly, improving the debt-to-equity ratio favorably. However, the return on equity has been negatively impacted by the net loss, which may be a potential risk if profitability issues persist.
Cash Flow
78
Positive
Cash flow metrics are solid, with a strong operating cash flow to net income ratio indicating effective cash generation from operations. Free cash flow has grown, showing good liquidity management. However, the substantial increase in financing cash flow suggests reliance on external funding, which could indicate potential liquidity concerns in the future if not managed well.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue2.71B1.72B1.66B1.59B1.40B1.73B
Gross Profit969.70M626.50M585.70M529.40M482.10M533.70M
EBITDA187.10M204.20M268.70M212.50M202.80M231.20M
Net Income-137.70M85.40M582.60M137.40M119.10M108.80M
Balance Sheet
Total Assets8.25B3.41B2.71B2.64B2.14B1.81B
Cash, Cash Equivalents and Short-Term Investments111.80M1.23B483.30M71.70M78.80M47.50M
Total Debt1.92B1.25B646.40M977.90M674.40M524.90M
Total Liabilities3.88B1.87B1.22B1.74B1.39B1.17B
Stockholders Equity4.37B1.54B1.49B905.40M750.20M637.10M
Cash Flow
Free Cash Flow281.80M194.70M19.10M50.60M123.20M217.70M
Operating Cash Flow337.20M232.60M74.20M135.20M174.90M252.00M
Investing Cash Flow-1.80B-41.30M729.30M-413.20M-270.50M-37.30M
Financing Cash Flow1.12B561.80M-354.10M270.60M80.80M-207.40M

JBT Marel Technical Analysis

Technical Analysis Sentiment
Positive
Last Price143.29
Price Trends
50DMA
133.54
Positive
100DMA
121.92
Positive
200DMA
123.18
Positive
Market Momentum
MACD
3.17
Positive
RSI
57.46
Neutral
STOCH
56.94
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JBTM, the sentiment is Positive. The current price of 143.29 is above the 20-day moving average (MA) of 140.54, above the 50-day MA of 133.54, and above the 200-day MA of 123.18, indicating a bullish trend. The MACD of 3.17 indicates Positive momentum. The RSI at 57.46 is Neutral, neither overbought nor oversold. The STOCH value of 56.94 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JBTM.

JBT Marel Risk Analysis

JBT Marel disclosed 59 risk factors in its most recent earnings report. JBT Marel reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

JBT Marel Peers Comparison

Overall Rating
UnderperformOutperform
Sector (64)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
79
Outperform
$9.24B29.7817.75%0.69%2.96%12.62%
78
Outperform
$8.75B41.8215.02%8.90%29.18%
75
Outperform
$4.12B27.8417.33%1.02%10.19%20.71%
74
Outperform
$7.02B24.3313.91%1.57%3.15%14.18%
72
Outperform
$7.45B40.40-4.70%0.28%64.69%-112.14%
69
Neutral
$2.46B43.988.37%0.63%9.64%-24.68%
64
Neutral
$10.74B15.868.15%2.00%2.70%-15.17%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JBTM
JBT Marel
143.29
56.03
64.21%
FLS
Flowserve
53.66
6.77
14.44%
MWA
Mueller Water Products
26.36
5.98
29.34%
SPXC
SPX
187.11
38.32
25.75%
SXI
Standex International
204.07
34.43
20.30%
WTS
Watts Water Technologies
276.90
85.00
44.29%

JBT Marel Corporate Events

Private Placements and Financing
JBT Marel Amends Credit Agreement to Lower Loan Costs
Positive
Aug 21, 2025

On August 20, 2025, JBT Marel Corporation, a Delaware corporation, executed an amendment to its Second Amended and Restated Credit Agreement to reduce the pricing of its Term B Loans. This amendment removes a ten basis point credit spread adjustment and lowers the applicable margin from SOFR plus 2.00%-2.50% to SOFR plus 1.75%, depending on the company’s Total Net Leverage Ratio. The agreement was executed with various parties including John Bean Technologies Corporation Europe B.V., its subsidiary guarantors, lenders, and Wells Fargo Bank as the administrative agent.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 22, 2025